Heymsfield SB, Coleman LA, Miller R, Rooks DS, Laurent D, Petricoul O, et al
This necessitates regular monitoring of thyroid function during active weight loss phases to avoid overtreatment, which can cause symptoms of hyperthyroidism including palpitations, anxiety, and bone loss
GLP-1 is typically used in combination with a reduced-calorie diet and increased physical activity
This hair loss is likely linked to telogen effluvium, a temporary condition caused by stress on the body, rather than a direct effect of the medication itself
The FDA does not evaluate compounded drug products for safety, effectiveness, or quality. The ad did not include verbal recognition of the fact its drugs are compounded or not FDA approved
Semaglutides 14.9% average weight loss is substantial